Genetics and Metabolism Program, University of Manitoba, Winnipeg, Manitoba, Canada.
Neuromuscul Disord. 2013 Mar;23(3):239-42. doi: 10.1016/j.nmd.2012.12.004. Epub 2013 Jan 8.
We describe the presentation and six-year follow up of a child with nemaline myopathy due to a de novo mutation in the skeletal muscle α-actin gene (ACTA1) characterized by dramatic improvement during the early childhood years. The presentation in this female patient was infantile-onset weakness in the facial, bulbar, respiratory and neck flexor muscles. A six-year follow-up revealed continued progressive improvement in her muscle strength. Based upon the histopathologic and ultrastructural features of nemaline rod disease, ACTA1 was sequenced. This revealed a mutation in exon 4 of ACTA1 (c.557A>G). Our report further expands the phenotypic spectrum associated with ACTA1 mutations. Although it is difficult to infer any genotype-phenotype correlation, this report stimulates the discussion regarding the pathophysiologic mechanism of the clinical improvement seen in some patients with ACTA1 mutations.
我们描述了一名儿童的表现和六年随访结果,该儿童患有肌原纤维性肌病,是由于骨骼肌α-肌动蛋白基因(ACTA1)的新生突变引起的,其特征是在幼儿期有明显改善。该女性患者的表现为婴儿期起病的面部、球部、呼吸和颈部屈肌无力。六年随访显示其肌肉力量持续渐进性改善。根据杆状肌病的组织病理学和超微结构特征,对 ACTA1 进行了测序。结果显示 ACTA1 外显子 4 中的突变(c.557A>G)。本报告进一步扩展了与 ACTA1 突变相关的表型谱。虽然很难推断任何基因型-表型相关性,但本报告激发了关于在一些 ACTA1 突变患者中观察到的临床改善的病理生理机制的讨论。